Rentabilitas dodolan miturut bathi resik Pheton Holdings (PTHL)

Lambang korporat lan logo ftzy.com.cn (PTHL)

The development of the technological base in China laid the foundation for expansion into Asian medtech. The net margin ratio of Pheton Holdings Ltd (PTHL) shows a peak, after which strong pricing power driven by AI-based brachytherapy planning strengthened the position of Pheton Holdings Ltd (PTHL). A stable staff of 3D developers minimizes personnel risks. The value of -790.60 determines the current status of the business efficiency parameter.

Margin resik Pheton Holdings (PTHL): kanggo periode 06.09.2024 - 16.01.2026

ftzy.com.cn (PTHL) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
- rincian kapitalisasi pasar:
Ringkesan analitik perusahaan:Pheton Holdings Ltd
Produk dadi Pheton Holdings Ltd

The complexity of configuring brachytherapy software ensures high customer loyalty and a stable cash flow for Pheton Holdings Ltd (PTHL). This metric is calculated as the ratio of net income to total revenue, reflecting the actual efficiency of cost management. By analyzing the net margin from every ruble of revenue, an investor can see the impact of PRC regulations on profitability. The trend of the curve allows for the identification of risks regarding overpaying for the asset. This is a key indicator of the sustainability of the ecosystem's business model.

Analisis perusahaan pesaing

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik SPRY|TBPH - Margin resik|Aquestive Pharma - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik scpharmaceuticals.com SCPH|Tectonic - Margin dodolan resik|TNXP - Margin dodolan resik|SXTC: Margin dodolan resik|Eupraxia Pharma - Tingkat bathi resik|BHST (bioharvest.com) - Margin dodolan resik|Rentabilitas dodolan resik EXOZ (invizyne.com)|Margin dodolan resik ORMP|Margin dodolan perusahaan Entera Bio|Margin dodolan resik HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Margin resik|Cumberland Corp - Margin dodolan resik|QNTM - Margin dodolan resik|FibroGen, Inc. (FGEN) - Margin resik|TELO: Rentabilitas resik perusahaan|RANI (Rani Therapeutics Inc) - Margin dodolan resik|Margin resik synergychc.com SNYR|Margin resik Rallybio Corp. (RLYB)|LEXX - Margin resik|Margin dodolan resik PULM (pulmatrix.com)|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma